CureVac N.V. (BIT:1CVAC)

CureVac Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	438.33	481.75	402.45	495.8	811.46	1,323
Cash & Short-Term Investments	438.33	481.75	402.45	495.8	811.46	1,323
Cash Growth	46.04%	19.70%	-18.83%	-38.90%	-38.65%	4014.84%
Accounts Receivable	3.96	16.84	17.08	9	18.5	1.82
Other Receivables	6.8	16.04	22.43	32.99	37.95	10.42
Receivables	10.76	32.88	39.51	41.99	56.45	12.25
Inventory	0.54	0.54	24.8	23.99	56.16	14.53
Prepaid Expenses	14.18	0.79	1.08	9.85	14.01	40.05
Other Current Assets	5.29	10.45	10.54	12.4	1.94	0.43
Total Current Assets	469.1	526.41	478.38	584.03	940.02	1,390
Property, Plant & Equipment	240.99	244.65	278.63	241.7	200.39	100.59
Goodwill	-	12.46	12.46	12.46	-	-
Other Intangible Assets	24.73	12.69	15.88	19.3	12.27	13.46
Long-Term Deferred Tax Assets	5.94	5.09	1.19	1.3	2.86	0.45
Long-Term Deferred Charges	-	-	-	-	0.52	1.03
Other Long-Term Assets	1.51	1.51	1.7	1.68	2.18	5.98
Total Assets	742.27	802.83	788.25	860.47	1,158	1,511
Accounts Payable	9.43	17.27	48.03	-	122.26	17.62
Accrued Expenses	-	11.13	10.54	78.29	9.36	19.19
Current Portion of Leases	5.2	5.32	5.01	4.98	3.47	3.23
Current Income Taxes Payable	18.42	18.25	0.65	0.61	0.74	0.39
Current Unearned Revenue	-	-	44.58	36.78	58.92	194.05
Other Current Liabilities	28.25	20.38	77.57	35.56	162.99	13.14
Total Current Liabilities	61.29	72.35	186.39	156.23	357.73	247.62
Long-Term Debt	-	-	-	-	-	25.19
Long-Term Leases	32.18	33.64	36.82	37.11	25.42	26.85
Long-Term Unearned Revenue	-	-	48.1	72.55	86.35	500.06
Long-Term Deferred Tax Liabilities	0.23	0.23	-	-	-	-
Other Long-Term Liabilities	1.88	-	-	61.34	0.26	0.28
Total Liabilities	95.58	106.22	271.31	327.22	469.77	800.01
Common Stock	27.02	26.92	26.88	23.4	22.45	21.66
Retained Earnings	-1,456	-1,404	-1,566	-1,306	-1,057	-645.07
Treasury Stock	-	-	-	-1.48	-5.82	-
Comprehensive Income & Other	2,076	2,073	2,056	1,817	1,729	1,335
Shareholders' Equity	646.69	696.61	516.94	533.25	688.48	711.35
Total Liabilities & Equity	742.27	802.83	788.25	860.47	1,158	1,511
Total Debt	37.38	38.97	41.82	42.09	28.89	55.28
Net Cash (Debt)	400.95	442.78	360.63	453.71	782.57	1,267
Net Cash Growth	54.50%	22.78%	-20.52%	-42.02%	-38.25%	-
Net Cash Per Share	1.79	1.97	1.63	2.40	4.21	9.59
Filing Date Shares Outstanding	225.16	225.16	223.99	194.95	187.03	180.46
Total Common Shares Outstanding	225.16	224.34	223.99	194.95	187.12	180.46
Working Capital	407.81	454.07	291.99	427.8	582.29	1,142
Book Value Per Share	2.87	3.11	2.31	2.74	3.68	3.94
Tangible Book Value	621.96	671.45	488.59	501.49	676.2	697.89
Tangible Book Value Per Share	2.76	2.99	2.18	2.57	3.61	3.87
Buildings	-	28.2	27.54	26.47	27.27	19.95
Machinery	-	71.64	67.68	62.59	63.47	31.63
Construction In Progress	-	183.65	178.99	138.46	124.54	39.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.